Pancreatic NETs frequently exhibit changes in genes such as MEN1, DAXX, ATRX, TSC1, TSC2, CDKN1A, and CDKN1B, along with alterations in CDKN2A and SETD2 in metastatic lesions. Here, SETD2 is linked to pancreatic neuroendocrine tumor.